KRISTINE YVETTE PALILEO: Open Payments
NPI 1891022273 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 12 payments from 8 companies in 2025. Trend: 2023 $200 · 2024 $131 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| Janssen Scientific Affairs, LLC | 1 | $139 |
| GENZYME CORPORATION | 1 | $107 |
| Janssen Biotech, Inc. | 4 | $71 |
| ABBVIE INC. | 2 | $41 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| PFIZER INC. | 1 | $18 |
Products named: DUPIXENT, TREMFYA, XIFAXAN, LINZESS, ENTYVIO, VELSIPITY, SKYRIZI.
Industry payments across CA — which companies pay providers there.
